These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Age-Related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin Among U.S. Adults Aged 50 or Older, 2011-2018. Rhee TG, Kumar M, Ross JS, Coll PP. J Am Geriatr Soc; 2021 May; 69(5):1272-1282. PubMed ID: 33598936 [Abstract] [Full Text] [Related]
8. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED. J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801 [Abstract] [Full Text] [Related]
10. A systematic review and economic evaluation of statins for the prevention of coronary events. Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N. Health Technol Assess; 2007 Apr 08; 11(14):1-160, iii-iv. PubMed ID: 17408535 [Abstract] [Full Text] [Related]
14. The role of statin therapy in older adults: best practices and unmet challenges. Stone J, Kumar M, Orkaby AR. Expert Rev Cardiovasc Ther; 2024 Jul 08; 22(7):301-311. PubMed ID: 38940676 [Abstract] [Full Text] [Related]
15. Intensive statin therapy for Indians: Part-I. Benefits. Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K. Indian Heart J; 2011 Jul 08; 63(3):211-27. PubMed ID: 22734339 [Abstract] [Full Text] [Related]
17. The evolution or revolution of statin therapy in primary prevention: where do we go from here? Rehfield P, Kopes-Kerr C, Clearfield M. Curr Atheroscler Rep; 2013 Feb 08; 15(2):298. PubMed ID: 23299639 [Abstract] [Full Text] [Related]
18. Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States. Mitchell AP, Simpson RJ. BMC Res Notes; 2012 Jul 24; 5():373. PubMed ID: 22828389 [Abstract] [Full Text] [Related]